Reneo Pharmaceuticals, Inc. (RPHM)
USD 18.2
(952.02%)
USD 18.2
(952.02%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Operating Cash Flow | -63.68 Million | -47.36 Million | -37.98 Million | -18.53 Million | -12.51 Million |
| Net Income | -77.38 Million | -51.95 Million | -39.77 Million | -19.46 Million | -12.43 Million |
| Depreciation & Amortization | 525 Thousand | 88 Thousand | 50 Thousand | 37 Thousand | 34 Thousand |
| Deferred income taxes | - | - | - | - | -2.73 Million |
| Stock-based compensation | 5112.00 | 4320.00 | 3891.00 | 393.00 | 388.00 |
| Change in working capital | 12.21 Million | 959 Thousand | -2.8 Million | 514 Thousand | 1.56 Million |
| Other non-cash items | 2.01 Million | -774 Thousand | 646 Thousand | -15 Thousand | 673 Thousand |
| Investing Cash Flow | 10.52 Million | -57.84 Million | -23.37 Million | 7.37 Million | -7.24 Million |
| Investments in PPE | -221 Thousand | -346 Thousand | -198 Thousand | -24 Thousand | -7000.00 |
| Acquisitions | - | 57.49 Thousand | 23.17 Thousand | - | 7234.00 |
| Investment purchases | -231.25 Million | -101.59 Million | -31.4 Million | - | -19.83 Million |
| Sales/Maturities of investments | 242 Million | 44.1 Million | 8.22 Million | 7.4 Million | 12.6 Million |
| Other Investing Activities | 10.74 Thousand | -57.49 Thousand | -23.17 Thousand | 7400.00 | -7234.00 |
| Financing Cash Flow | 60.86 Million | 471 Thousand | 132.4 Million | 47.27 Million | 24.98 Million |
| Debt repayment | - | - | - | - | - |
| Dividends payments | - | - | - | - | - |
| Common Stock Repurchased | -4.4 Million | - | - | - | - |
| Common Stock Issuance | 65.26 Million | 278 Thousand | 132.4 Million | 47.27 Million | 24.98 Million |
| Other Financing Activities | 65.26 Thousand | 193 Thousand | 132.4 Thousand | 47.27 Thousand | 24.98 Thousand |
| Accounts receivables | - | - | - | - | - |
| Accounts payables | 11.11 Million | 518 Thousand | 1.78 Million | 1.48 Million | 1.03 Million |
| Inventory | - | - | - | - | - |
| Other working capital | 12.21 Million | 441 Thousand | -4.58 Million | -972 Thousand | 527 Thousand |
| Cash at beginning of period | 19.92 Million | 124.66 Million | 53.61 Million | 17.5 Million | 12.26 Million |
| Cash at end of period | 27.63 Million | 19.92 Million | 124.66 Million | 53.61 Million | 17.5 Million |
| Capital Expenditure | -221 Thousand | -346 Thousand | -198 Thousand | -24 Thousand | -7000.00 |
| Effect of forex changes on cash | - | - | - | - | - |
| Net cash flow / Change in cash | 7.7 Million | -104.73 Million | 71.04 Million | 36.11 Million | 5.23 Million |
| Free Cash Flow | -63.9 Million | -47.7 Million | -38.18 Million | -18.56 Million | -12.51 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -5.36 Million | -8.42 Million | -77.38 Million | -23.55 Million | -19.19 Million | -19.53 Million |
| Depreciation & Amortization | 12 Thousand | 16 Thousand | 525 Thousand | 44 Thousand | 43 Thousand | 42 Thousand |
| Deferred income taxes | - | - | - | 2.77 Million | -1.53 Million | -1.24 Million |
| Stock-based compensation | 989 Thousand | 1.07 Million | 5112.00 | 1.31 Million | 1.42 Million | 1.2 Million |
| Change in working capital | -1.78 Million | -12.85 Million | 12.21 Million | 4.08 Million | 189 Thousand | 2.73 Million |
| Other non-cash items | 1.81 Million | 15.65 Million | 2.01 Million | -235 Thousand | 306 Thousand | 673 Thousand |
| Investing Cash Flow | 22.49 Million | 13.75 Million | 10.52 Million | 39.77 Million | 21.25 Million | -69.01 Million |
| Investments in PPE | -2000.00 | - | -221 Thousand | -25 Thousand | -19 Thousand | -5000.00 |
| Acquisitions | - | - | - | -50.32 Thousand | - | 69 Thousand |
| Investment purchases | -22.5 Million | -45.24 Million | -231.25 Million | -41.19 Million | -57.73 Million | -104 Million |
| Sales/Maturities of investments | 45 Million | 59 Million | 242 Million | 81 Million | 79 Million | 35 Million |
| Other Investing Activities | 22.49 Million | 13.75 Million | 10.74 Thousand | 39.8 Thousand | 21.26 Thousand | -69 Thousand |
| Financing Cash Flow | -89 Thousand | - | 60.86 Million | -4.12 Million | 173 Thousand | 63.81 Million |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | -4.4 Million | -4.4 Million | - | - |
| Common Stock Issuance | -89 Thousand | - | 65.26 Million | 275 Thousand | 173 Thousand | 63.52 Million |
| Other Financing Activities | -89 Thousand | - | 65.26 Thousand | 275.00 | 173.00 | 282 Thousand |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | -1.46 Million | -15.36 Million | 11.11 Million | 4.61 Million | -183 Thousand | 3.29 Million |
| Inventory | - | - | - | - | - | - |
| Other working capital | -317 Thousand | 2.5 Million | 12.21 Million | 10.58 Million | 372 Thousand | -556 Thousand |
| Cash at beginning of period | 20.37 Million | 27.63 Million | 19.92 Million | 11.73 Million | 9.08 Million | 30.39 Million |
| Cash at end of period | 35.97 Million | 20.37 Million | 27.63 Million | 27.63 Million | 11.73 Million | 9.08 Million |
| Capital Expenditure | -2000.00 | - | -221 Thousand | -25 Thousand | -19 Thousand | -5000.00 |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 15.59 Million | -7.25 Million | 7.7 Million | 15.89 Million | 2.65 Million | -21.31 Million |
| Free Cash Flow | -6.8 Million | -21.01 Million | -63.9 Million | -19.77 Million | -18.78 Million | -16.11 Million |
SRM
LEL
1776
1463
IEX
MODIPON